Show simple item record

dc.contributor.authorBaban, Babak
dc.contributor.authorPenberthy, W. Todd
dc.contributor.authorMozaffari, Mahmood S.
dc.date.accessioned2012-10-26T16:40:52Z
dc.date.available2012-10-26T16:40:52Z
dc.date.issued2010-03-19en_US
dc.identifier.citationEPMA J. 2010 Mar 19; 1(1):46-55en_US
dc.identifier.issn1878-5085en_US
dc.identifier.doi10.1007/s13167-010-0009-2en_US
dc.identifier.urihttp://hdl.handle.net/10675.2/720
dc.description.abstractKeywords: Individual tolerance
dc.rights© European Association for Predictive, Preventive and Personalised Medicine 2010en_US
dc.subjectReview Articleen_US
dc.titleThe potential role of indoleamine 2,3 dioxygenase (IDO) as a predictive and therapeutic target for diabetes treatment: a mythical truthen_US
dc.typeArticleen_US
dc.identifier.pmcidPMC3405305en_US
dc.contributor.corporatenameDepartment of Oral Biology
refterms.dateFOA2019-04-10T00:40:08Z
html.description.abstractKeywords: Individual tolerance


Files in this item

Thumbnail
Name:
13167_2010_Article_9.pdf
Size:
287.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record